Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
about
Bacterial complications during pandemic influenza infection.Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus.Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination PostinfluenzaPreventing and treating secondary bacterial infections with antiviral agentsKinetics of coinfection with influenza A virus and Streptococcus pneumoniae.Mathematical model of a three-stage innate immune response to a pneumococcal lung infectionImmunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenzaDepletion of alveolar macrophages during influenza infection facilitates bacterial superinfectionsTreatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza.Animal models for the study of influenza pathogenesis and therapy.Discovery and Characterization of Diazenylaryl Sulfonic Acids as Inhibitors of Viral and Bacterial Neuraminidases.Immune dysfunction and bacterial coinfections following influenza.Free actin impairs macrophage bacterial defenses via scavenger receptor MARCO interaction with reversal by plasma gelsolin.Super-infection with Staphylococcus aureus inhibits influenza virus-induced type I IFN signalling through impaired STAT1-STAT2 dimerization.Association Between the Order of Macrolide and Cephalosporin Treatment and Outcomes of PneumoniaAdjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.
P2860
Q30228111-1F51669E-E092-475F-A509-221976A9853BQ30386537-287EEA59-79E9-4081-8E8B-9B72A8067D98Q30394781-B7693698-3FFC-455D-94A0-7FE4E07412B3Q30401260-4EBF6245-0A38-49E8-AB7B-12AA2DB125E9Q30429002-D316C8B0-EA48-4A90-B6D6-092AF1CDFD34Q34733562-401C28CC-DB0C-40A2-B8D5-5586A3904D44Q34933070-CEDFC398-B129-4258-85CB-913B23B23700Q35557119-ED3B1465-CB3C-45F3-99BD-C0B0B534094CQ37002972-4222F05C-0E78-4A04-B962-3E1A361AFEFFQ37203889-DFEE2228-C493-498C-A614-F9FD331BFE3EQ37379466-D5699735-8997-4C5E-AEDB-626AD9509018Q37642063-8E8484F6-68E4-4355-B5CA-4828A6AB3795Q38130488-E162BA9E-232A-4276-B46F-75828E2DDA72Q38708583-B26DD42C-B978-41BF-BC1E-AF2FC04F8436Q38949889-0E528B78-F0C6-46C2-90E6-D56827C4492BQ41694434-6D8B845B-BD03-4129-B6E3-026C00F2166EQ42239416-DAC2E58E-F264-4749-9E16-CAEAA752169A
P2860
Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
@en
type
label
Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
@en
prefLabel
Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
@en
P2860
P356
P1433
P1476
Improving therapeutic strategies for secondary bacterial pneumonia following influenza.
@en
P2093
B Keith English
P2860
P304
P356
10.2217/17460913.3.4.397
P577
2008-08-01T00:00:00Z